Africa Eastern and Southern vs Nicaragua: Immunization, measles second dose
Africa Eastern and Southern
57.1%
in 2024
Nicaragua
95.0%
in 2023
Africa Eastern and Southern rank
36th
Nicaragua rank
33rd
Immunization, measles second dose over time
- Africa Eastern and Southern
- Nicaragua
How they compare
Nicaragua currently reports 95.0% against 57.1% in Africa Eastern and Southern, a difference of 37.9%.
That makes Nicaragua's figure about 1.7 times Africa Eastern and Southern's.
Across all 7 years both countries report, Nicaragua has been ahead every year.
Africa Eastern and Southern ranks 36th and Nicaragua ranks 33rd of 43 groups.
Nicaragua has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa Eastern and Southern | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 34.9% | 92.7% | 57.7% | Nicaragua |
| 2020s | 44.1% | 93.8% | 49.6% | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Africa Eastern and Southern or Nicaragua?
- Nicaragua, at 95.0% against 57.1% in Africa Eastern and Southern as of 2023.
- What is the difference in immunization, measles second dose between Africa Eastern and Southern and Nicaragua?
- 37.9%, with Nicaragua ahead.
- How many years of comparable data are there for Africa Eastern and Southern and Nicaragua?
- 7 years are reported by both, from 2017 to 2023.
- How do Africa Eastern and Southern and Nicaragua rank globally for immunization, measles second dose?
- Africa Eastern and Southern ranks 36th and Nicaragua ranks 33rd of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.